All Updates

All Updates

icon
Filter
Partnerships
Paragon Genomics partners with Biosecure ID to distribute CleanPlex products in UK and Ireland
Precision Medicine
Jul 9, 2024
This week:
Partnerships
Qualcomm and Google partner to develop AI-driven automotive solutions
Auto Tech
Yesterday
Product updates
Meta AI releases LayerSkip to accelerate inference in LLMs
Generative AI Infrastructure
Yesterday
Funding
Freeform secures funding from NVIDIA's NVentures
Additive Manufacturing
Oct 22, 2024
Product updates
Flexxbotics announces compatibility with LMI Technologies for quality inspection
Smart Factory
Oct 22, 2024
Funding
Oxla raises USD 11 million in seed funding to drive commercialization
Data Infrastructure & Analytics
Oct 22, 2024
Product updates
Cohesity enhances Gaia, its AI assistant, with visual data exploration and expanded data sources
Data Infrastructure & Analytics
Oct 22, 2024
Product updates
Finzly launches FedNow service through BankOS platform in AWS marketplace
FinTech Infrastructure
Oct 22, 2024
Product updates
Runway launches Act-One for AI facial expression motion capture
Generative AI Applications
Oct 22, 2024
Product updates
Ideogram launches Canvas for image manipulation and generation
Generative AI Applications
Oct 22, 2024
Partnerships
UiPath partners with Inflection AI to integrate AI solutions for enterprises
Generative AI Applications
Oct 22, 2024
Precision Medicine

Precision Medicine

Jul 9, 2024

Paragon Genomics partners with Biosecure ID to distribute CleanPlex products in UK and Ireland

Partnerships

  • Paragon Genomics has partnered with Biosecure ID to distribute its technology in the UK and Ireland. Biosecure ID is a for-profit unit of Science Social for Good CIC, an organization dedicated to genetic research and testing services.

  • This partnership aims to expand the availability of Paragon's CleanPlex technology in these markets. CleanPlex offers ultra-high multiplexed target enrichment technology for NGS assays for research and diagnostics. The assay is compatible with major sequencing platforms, including Illumina, Ion Torrent, MGI DNBSeq, and Singular Genomics. The product is available in ready-to-use or custom NGS panels. 

  • Paragon Genomics develops and commercializes PCR-based target enrichment solutions for next-generation sequencing (NGS). The company's proprietary CleanPlex technology enables the development of custom and fixed NGS panels for various applications, including oncology, infectious diseases, and genetic disorders. It focuses on providing cost-effective solutions with high sensitivity and is designed to advance precision medicine by supporting genomic profiling and targeted sequencing.​

Contact us

Gain access to all industry hubs, market maps, research tools, and more
Get a demo
arrow
menuarrow

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.